New research reveals that patients who stop using popular GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds far faster than those who halt traditional diet and exercise regimens.
Findings released in a major medical journal shows that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals buying these medications should be aware of the potential of quick weight regain when the medication is stopped," warns expert Dr. Susan Jebb.
Such speed of regain suggests a reversion to starting weight within about a year and a half.
Weighing Approaches
The analysis, which looked at dozens of trials involving over 9,000 of participants, compared the effects of GLP-1 agonists with other pills.
Scientists emphasize that people who shed pounds through diet and exercise usually experience a slower weight regain—approximately 100 grams monthly—post-intervention.
Understanding the Quick Regain
Experts propose the mechanism of the injections is key to understanding the heightened weight return.
These medications mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Sustained high doses of GLP-1 concentrations far above than the body's typical production might result in the system to generate a reduced amount of its endogenous GLP-1, and may also reduce sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' means hunger is unsuppressed, making excessive eating much more probable."
A Chronic Condition?
The NHS recommend the jabs for people with obesity-related medical conditions, alongside recommended diet and exercise modifications.
A number of clinicians argue that, due to the significant potential of relapse, the treatment is often ongoing.
This opinion is echoed by drug manufacturers, who state that the findings "emphasize the chronic character of obesity," comparing it to managing diseases like diabetes.
Patient Experiences
People who have stopped the medication describe a powerful resurgence of hunger.
"It felt as if a trigger that goes on and I was suddenly ravenous," recalled one woman.
This challenge is worsened if users have not adopted lasting lifestyle or habit changes during therapy.
Growing Adoption
Recent estimates indicate that a significant number of people in the UK have used these injections in the past year, with desire being substantial.
- Use is more common among females than men.
- The middle-aged demographic shows the highest level of interest.
- A large proportion obtain the medications through private healthcare rather than public health services.
Finally, clinicians caution that while the jabs are potent agents for shedding pounds, they are not a magic fix and maintained weight loss hinges on combined behavioural management.
